insights_auto
Why is AKESF up 2.04%?
Dive Deeperchevron_right
AKESF:OTCMKTS
Akeso Inc
$11.48
arrow_upward
+2.04%(+0.23) 1D
Oct 19, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AKESF...
Open
$11.75
High
$12.00
Low
$11.48
Mkt. cap
84.10B
Avg. vol.
3.25K
Volume
1.84K
52-wk high
$19.49
52-wk low
$10.50
Beta
2,863.94
Shares outstanding
941.14M
No. of employees
4K
Open
$11.75
High
$12.00
Low
$11.48
Mkt. cap
84.10B
Avg. vol.
3.25K
Volume
1.84K
52-wk high
$19.49
52-wk low
$10.50
Beta
2,863.94
Shares outstanding
941.14M
No. of employees
4K
News stories
From web sources and news partners
Yahoo Finance
·
1 day ago
Will Phase III Colon Cancer Trial Change Akeso Stock Narrative
Profile
Akeso, Inc is a publicly listed Chinese biopharmaceutical company that is headquartered in Zhongshan, Guangdong.
It is best known for developing Ivonescimab, a cancer treatment antibody. Wikipedia
About Akeso Inc
CEOMichelle Xia | Michelle Xia
Employees4.08K
FoundedMar 19, 2012
Headquarters-
SectorBiotechnology
Websiteakesobio.com